These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 26048604)

  • 1. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of nerve conduction studies in myotonic dystrophy type 1: primary involvement of nerves or incidental coexistence?
    Bae JS; Kim OK; Kim SJ; Kim BJ
    J Clin Neurosci; 2008 Oct; 15(10):1120-4. PubMed ID: 18657426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy in patients with myotonic dystrophy type 2.
    Leonardis L
    Acta Neurol Scand; 2017 May; 135(5):568-575. PubMed ID: 27401721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy in myotonic dystrophy type 1.
    Hermans MC; Faber CG; Vanhoutte EK; Bakkers M; De Baets MH; de Die-Smulders CE; Merkies IS
    J Peripher Nerv Syst; 2011 Mar; 16(1):24-9. PubMed ID: 21504499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
    Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
    Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
    Tieleman AA; van Vliet J; Jansen JB; van der Kooi AJ; Borm GF; van Engelen BG
    Neuromuscul Disord; 2008 Aug; 18(8):646-9. PubMed ID: 18602828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in adult myotonic dystrophies: a longitudinal study.
    Sansone V; Gandossini S; Cotelli M; Calabria M; Zanetti O; Meola G
    Neurol Sci; 2007 Mar; 28(1):9-15. PubMed ID: 17385090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).
    Gaul C; Schmidt T; Windisch G; Wieser T; Müller T; Vielhaber S; Zierz S; Leplow B
    Neurology; 2006 Jul; 67(2):350-2. PubMed ID: 16864839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2.
    Rossi S; Romano A; Modoni A; Perna F; Rizzo V; Santoro M; Monforte M; Pieroni M; Luigetti M; Pomponi MG; Silvestri G
    Eur Neurol; 2018; 79(3-4):166-170. PubMed ID: 29533949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysphagia is present but mild in myotonic dystrophy type 2.
    Tieleman AA; Knuijt S; van Vliet J; de Swart BJ; Ensink R; van Engelen BG
    Neuromuscul Disord; 2009 Mar; 19(3):196-8. PubMed ID: 19167224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
    Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive conduction disturbance in myotonic dystrophy.
    Palazzolo J; Trucco E; Arce M; Riera AR; Femenía F
    Cardiol J; 2011; 18(3):322-5. PubMed ID: 21660927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiological features of patients with myotonic dystrophy type 1].
    Li M; Wang ZJ; Cui F; Yang F; Chen ZH; Ling L; Huang XS
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(5):345-7. PubMed ID: 23660205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
    Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.